<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007060.ref009">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Aliota</surname>
   <given-names>MT</given-names>
  </name>, 
  <name>
   <surname>Bassit</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Bradrick</surname>
   <given-names>SS</given-names>
  </name>, 
  <name>
   <surname>Cox</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Garcia-Blanco</surname>
   <given-names>MA</given-names>
  </name>, 
  <name>
   <surname>Gavegnano</surname>
   <given-names>C</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network</article-title>. 
  <source>Antiviral Res</source>. 
  <year>2017</year>;
  <volume>144</volume>:
  <fpage>223</fpage>â€“
  <lpage>46</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.06.001</pub-id>
  <?supplied-pmid 28595824?>
  <pub-id pub-id-type="pmid">28595824</pub-id>
 </mixed-citation>
</ref>
